Company

TSH Biopharm Corp Ltd

Headquarters: Taipei, Taiwan

Employees: 76

TWSE: 8432 +1.17%

Market Cap

TW$1.85 Billion

TWD as of July 1, 2025

US$63.2 Million

Market Cap History

TSH Biopharm Corp Ltd Categories

Taiwan Healthcare Drug Manufacturers—Specialty & Generic
Taiwan Healthcare Taiwan Drug Manufacturers—Specialty & Generic

TSH Biopharm Corp Ltd market capitalization over time

Evolution of TSH Biopharm Corp Ltd market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of TSH Biopharm Corp Ltd

Top Competitors by Market Capitalization

Industry: Drug Manufacturers—Specialty & Generic
Company Market Cap (USD)
Zoetis Inc. $70.87 B
MERCK Kommanditgesellschaft auf Aktien $55.96 B
Takeda Pharmaceutical Company Limited $48.34 B
Haleon plc $46.46 B
Hansoh Pharmaceutical Group Company Ltd $23.59 B
Sector:
Company Market Cap (USD)
Lilly $699.59 B
Johnson & Johnson $374.29 B
AbbVie $336.94 B
Novo Nordisk $309.91 B
UnitedHealth Group $279.90 B

Detailed Description

TSH Biopharm Corporation Limited develops and markets medicines for chronic diseases in Taiwan. It offers products for cardiovascular, central nervous, gastrointestinal, and others, as well as liquid-biopsy diagnosis. The company is headquartered in Taipei city, Taiwan. TSH Biopharm Corporation Limited is a subsidiary of TTY Biopharm Company Limited.

Stocks & Indices

TSH Biopharm Corp Ltd has the following listings and related stock indices.


Stock: TWSE: 8432 wb_incandescent

Details

Headquarters:

No. 3-1, Park Street

3rd Floor-1 Nangang District

Taipei, 11503

Taiwan

Phone: 886 2 2655 8525

Fax: 886 2 2655 8526